Oncobit
Oncobit develops precision oncology solutions focused on monitoring circulating tumor DNA (ctDNA) through digital PCR technology. The company provides diagnostic tests and standardized software to help clinicians track disease progression and treatment response in melanoma and uveal melanoma patients. Their products, including CE-IVDR marked solutions, utilize blood samples to offer therapy-decision support for physicians and biopharma partners.
Visit websiteZürich, Switzerland
Healthtech
Diagnostics
Biotechnology
Precision Oncology
Funding summary
- Total raised
- €4.2M
- Funding rounds
- 2
Investors in Oncobit
Investors on record for Oncobit. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Oncobit?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors